Neuromusculoskeletal Medicine & OMM · Neptune, NJ
NPI
1114187465
Since 2008
Specialty
Neuromusculoskeletal Medicine & OMM
Code 204D00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1945 Corlies Ave
Neptune, NJ, 07753
Phone (732) 897-3600
Groups this clinician bills Medicare through
Medicare paid, 2024
$100K
1,069 services
Medicare patients, 2024
495
Average age 75
Drug cost, 2024
$5.0M
1,435 prescriptions
Company payments, 2025
$2,163
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary Sedarous was code 99214 (office e&m - established), 240 times for 199 patients. In total Mary Sedarous billed 1,069 services in 35 codes, and Medicare paid $100K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 240 | 199 | $89.61 | $22K |
| G0453 Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 165 | 23 | $26.37 | $4,351 |
| 99204 Office E&M - New | Office | 99 | 99 | $120.89 | $12K |
| 99215 Office E&M - Established | Office | 66 | 45 | $144.17 | $9,515 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 65 | 52 | $13.95 | $907 |
| 95885 Electrical Nerve Conductivity | Office | 52 | 32 | $53.15 | $2,764 |
| 95816 Neurologic | Office | 42 | 42 | $322.36 | $14K |
| 95886 Electrical Nerve Conductivity | Office | 37 | 35 | $83.60 | $3,093 |
| 99213 Office E&M - Established | Office | 35 | 35 | $63.81 | $2,233 |
| 99205 Office E&M - New | Office | 26 | 26 | $173.39 | $4,508 |
| 99222 Hospital E&M - Initial | Facility | 26 | 26 | $105.85 | $2,752 |
| 95910 Electrical Nerve Conductivity | Office | 25 | 25 | $145.67 | $3,642 |
| 95911 Electrical Nerve Conductivity | Office | 25 | 25 | $170.88 | $4,272 |
| 95816 Neurologic | Facility | 19 | 14 | $47.00 | $893 |
| 99223 Hospital E&M - Initial | Facility | 15 | 15 | $144.98 | $2,175 |
By year: 2022 $162K for 1,559 services; 2023 $196K for 2,033 services; 2024 $100K for 1,069 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mary Sedarous prescribed most often to Medicare patients was Donepezil Hcl, with 142 prescriptions and refills. In total Mary Sedarous wrote 1,435 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 142 | 313 | 44 | $1,596 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 121 | 316 | 43 | $3,272 |
| Levetiracetam Generic | 96 | 178 | 21 | $2,474 |
| Gabapentin Generic | 92 | 210 | 34 | $972 |
| Memantine Hcl Generic | 87 | 156 | 22 | $2,778 |
| Pyridostigmine Bromide Generic | 86 | 171 | 26 | $6,323 |
| Prednisone Generic | 51 | 85 | 12 | $427 |
| Riluzole Generic | 42 | 58 | 12 | $4,276 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 42 | 42 | Under 11 | $652K |
| Mycophenolate Mofetil Generic | 39 | 55 | Under 11 | $6,476 |
| Amitriptyline Hcl Generic | 36 | 74 | 11 | $274 |
| Ultomiris Ravulizumab-Cwvz | 34 | 46 | Under 11 | $1.6M |
| Sodium Chloride 0.9 % Sodium Chloride | 31 | 36 | Under 11 | $155 |
| Vyvgart Efgartigimod Alfa-Fcab | 30 | 33 | Under 11 | $1.9M |
| Azathioprine Generic | 27 | 77 | Under 11 | $2,600 |
Brand drugs: 301 claims; generic drugs: 1,134 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary Sedarous $2,163 ($2,163 in general payments such as food, travel and fees) from 25 companies. The largest payer was UCB, Inc. with $496.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 23 | $496 |
| Biogen, Inc. BIIB | 5 | $307 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $219 |
| Abbvie Inc. ABBV | 10 | $198 |
| Pfizer Inc. PFE | 13 | $153 |
| Argenx US, Inc. ARGX | 6 | $97.71 |
| Tanabe Pharma America, Inc. | 5 | $85.79 |
| Teva Pharmaceuticals USA, Inc. TEVA | 4 | $63.36 |
| Servier Pharmaceuticals LLC | 3 | $57.35 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $54.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.